From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Midwich – “Trading Update”, it now clear why it was previously “full year expectations unchanged” which were reluctant to speak their name?…

By Steve Moore | Monday 21 October 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Most recently writing on audio visual distribution group Midwich (MIDW), just last month with the shares at 324p I concluded its then-stated “full year expectations unchanged” reluctantly speak their name because at the half-year adjusted operating profit was down more than 15% and it admitted “the board expects macroeconomic conditions to remain challenging in certain markets for the remainder of this year” but full year expectations were stated in May as “now expect adjusted operating profit for the full year to be broadly in line with that achieved in 2023”. As such, I concluded still avoid/sell. The shares most recently closed at 320p, and today a “Trading Update” announcement commencing it is also “providing… revised guidance for the year ending 31 December 2024”. Uh oh!

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 11:08:31